Cancer related outcome after instillation of BCG Vs Gemcitabine & Docetaxel(Anticancer drugs) sequentially in superficial bladder cancer.
Not Applicable
- Conditions
- Health Condition 1: C679- Malignant neoplasm of bladder, unspecified
- Registration Number
- CTRI/2020/08/027427
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Intermediate & High risk Non Muscle Invasive Bladder Cancer
Exclusion Criteria
Muscle invasive carcinoma urinary bladder
Variant Histology
Incomplete TURBT
Pregnant & lactating women
Hepatic & Renal dysfunction
Uncontrolled UTI
Immunodeficient patient
Denial of consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method